BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34350670)

  • 21. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
    Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
    Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X
    Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HOTAIR-mediated reciprocal regulation of EZH2 and DNMT1 contribute to polyphyllin I-inhibited growth of castration-resistant prostate cancer cells in vitro and in vivo.
    Xiang S; Zou P; Tang Q; Zheng F; Wu J; Chen Z; Hann SS
    Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):589-599. PubMed ID: 29221985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rottlerin inhibits cell growth and invasion via down-regulation of EZH2 in prostate cancer.
    Zheng N; Wang L; Hou Y; Zhou X; He Y; Wang Z
    Cell Cycle; 2018; 17(21-22):2460-2473. PubMed ID: 30394832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of cell division cycle-associated protein 7 (CDCA7) suppresses cell proliferation, arrests cell cycle of ovarian cancer, and restrains angiogenesis by modulating enhancer of zeste homolog 2 (EZH2) expression.
    Cai C; Peng X; Zhang Y
    Bioengineered; 2021 Dec; 12(1):7007-7019. PubMed ID: 34551671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo.
    Hu S; Yu L; Li Z; Shen Y; Wang J; Cai J; Xiao L; Wang Z
    Cancer Biol Ther; 2010 Oct; 10(8):788-95. PubMed ID: 20686362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MAPRE3 as an epigenetic target of EZH2 restricts ovarian cancer proliferation in vitro and in vivo.
    Zhang Y; Liu F; Zheng J; Jiang K; Ai H; Liu L; Mao D
    Exp Cell Res; 2024 Feb; 435(1):113913. PubMed ID: 38199479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hsa_circ_0071589 promotes carcinogenesis via the miR-600/EZH2 axis in colorectal cancer.
    Yong W; Zhuoqi X; Baocheng W; Dongsheng Z; Chuan Z; Yueming S
    Biomed Pharmacother; 2018 Jun; 102():1188-1194. PubMed ID: 29710537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lidocaine inhibits glioma cell proliferation, migration and invasion by modulating the circEZH2/miR-181b-5p pathway.
    Wen J; Li X; Ding Y; Zheng S; Xiao Y
    Neuroreport; 2021 Jan; 32(1):52-60. PubMed ID: 33252475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA SNGH7 Is activated by SP1 and exerts oncogenic properties by interacting with EZH2 in ovarian cancer.
    Bai Z; Wu Y; Bai S; Yan Y; Kang H; Ma W; Zhang J; Gao Y; Hui B; Ma H; Li R; Zhang X; Ren J
    J Cell Mol Med; 2020 Jul; 24(13):7479-7489. PubMed ID: 32420685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma.
    Huang B; Huang M; Li Q
    Pathol Res Pract; 2018 Dec; 214(12):1980-1986. PubMed ID: 30274685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Chinese herbs Scutellaria baicalensis and Fritillaria cirrhosa target NFκB to inhibit proliferation of ovarian and endometrial cancer cells.
    Kavandi L; Lee LR; Bokhari AA; Pirog JE; Jiang Y; Ahmad KA; Syed V
    Mol Carcinog; 2015 May; 54(5):368-78. PubMed ID: 24249479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DEAD-box helicase 56 functions as an oncogene promote cell proliferation and invasion in gastric cancer via the FOXO1/p21 Cip1/c-Myc signaling pathway.
    Wang J; Wang Y; Wang J; Zhang S; Yu Z; Zheng K; Fu Z; Wang C; Huang W; Chen J
    Bioengineered; 2022 May; 13(5):13970-13985. PubMed ID: 35723050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isothiocyanate Iberin inhibits cell proliferation and induces cell apoptosis in the progression of ovarian cancer by mediating ROS accumulation and GPX1 expression.
    Gong TT; Guo Q; Li X; Zhang TN; Liu FH; He XH; Lin B; Wu QJ
    Biomed Pharmacother; 2021 Oct; 142():111533. PubMed ID: 34148735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of Long Noncoding RNA HOTAIR and EZH2 Induces Apoptosis and Inhibits Proliferation, Invasion, and Migration of Human Breast Cancer Cells.
    Han L; Zhang HC; Li L; Li CX; Di X; Qu X
    Cancer Biother Radiopharm; 2018 Aug; 33(6):241-251. PubMed ID: 30048163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity.
    Özeş AR; Pulliam N; Ertosun MG; Yılmaz Ö; Tang J; Çopuroğlu E; Matei D; Özeş ON; Nephew KP
    Oncogene; 2018 Jun; 37(26):3589-3600. PubMed ID: 29576612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase.
    Hu XW; Meng D; Fang J
    Carcinogenesis; 2008 Dec; 29(12):2369-76. PubMed ID: 18974065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Berbamine suppresses cell proliferation and promotes apoptosis in ovarian cancer partially via the inhibition of Wnt/β-catenin signaling.
    Zhang H; Jiao Y; Shi C; Song X; Chang Y; Ren Y; Shi X
    Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):532-539. PubMed ID: 29701777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Songorine suppresses cell growth and metastasis in epithelial ovarian cancer via the Bcl‑2/Bax and GSK3β/β‑catenin signaling pathways.
    Zhang H; Dong R; Zhang P; Wang Y
    Oncol Rep; 2019 May; 41(5):3069-3079. PubMed ID: 30896826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scutellarein inhibits the development of colon cancer via CDC4‑mediated RAGE ubiquitination.
    Li Y; Wang J; Zhong S; Li J; Du W
    Int J Mol Med; 2020 Apr; 45(4):1059-1072. PubMed ID: 32124957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.